ALTIMMUNE, INC.

ALT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2011 FY2010
Revenue $10.7M $3.2M $24.3M $21.0M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $18.4M $7.2M $21.2M $20.9M
SG&A Expense $8.5M $7.1M $14.3M $18.0M
Operating Income $-52.0M $-11.1M $-11.7M $-23.6M
Operating Margin -484.7% -342.7% -48.3% -112.2%
Interest Expense $162.1K $38.5K $54.6K $5.9M
Pretax Income $-52.1M $-11.1M $-3.8M $-34.8M
Income Tax Expense $-5.6M $0
Net Income $-46.4M $-11.1M $-3.8M $-34.8M
Net Margin -432.3% -342.6% -15.6% -166.0%
EPS (Basic) $-118.91 $2.97 $-0.08 $-1.08
EPS (Diluted) $-118.91 $2.95 $-0.08 $-1.08
Shares Outstanding (Basic) 608.5K 65.3M 48.2M 46.2M
Shares Outstanding (Diluted) 608.5K 65.7M 48.2M 46.2M
Dividends Per Share
← Newer Page 2 of 2 Older →